Cuba’s five COVID-19 vaccines:the full story on Soberana 01/02/Plus, Abdala, and Mambisa
Yaffe, Helen
(2021)
Cuba’s five COVID-19 vaccines:the full story on Soberana 01/02/Plus, Abdala, and Mambisa.
[['eprint_typename_blog_post' not defined]]
Despite its limited material resources, Cuba is responsible for developing two of only 23 coronavirus vaccines to have entered phase III trials anywhere in the world – and it has another three on the way. Helen Yaffe (University of Glasgow) explains how the Soberana, Abdala, and Mambisa vaccines work; how they will roll out at home and abroad; and how Cuba managed to produce them against the clock and against the odds.
| Item Type | ['eprint_typename_blog_post' not defined] |
|---|---|
| Keywords | coronavirus,Covid-19 |
| Departments | LSE |
| Date Deposited | 04 May 2021 10:15 |
| URI | https://researchonline.lse.ac.uk/id/eprint/110164 |
-
picture_as_pdf -
subject - Published Version
Download this file
Share this file
Downloads